These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 38299802)

  • 1. Evolving mechanisms and presentations of cardiovascular disease in people with HIV: implications for management.
    Nazari I; Feinstein MJ
    Clin Microbiol Rev; 2024 Mar; 37(1):e0009822. PubMed ID: 38299802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention and treatment of cardiovascular disease in HIV: practical insights in an evolving field.
    Avgousti H; Feinstein MJ
    Top Antivir Med; 2023 Dec; 31(5):559-565. PubMed ID: 38198667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association.
    Feinstein MJ; Hsue PY; Benjamin LA; Bloomfield GS; Currier JS; Freiberg MS; Grinspoon SK; Levin J; Longenecker CT; Post WS
    Circulation; 2019 Jul; 140(2):e98-e124. PubMed ID: 31154814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV and Cardiovascular Disease: From Insights to Interventions.
    Feinstein MJ
    Top Antivir Med; 2021; 29(4):407-411. PubMed ID: 34856094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular Disease Risk Among Transgender People with HIV.
    Cetlin M; Fulda ES; Chu SM; Hamnvik OR; Poteat T; Zanni MV; Toribio M
    Curr HIV/AIDS Rep; 2021 Oct; 18(5):407-423. PubMed ID: 34626323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular Disease Risk Factor Control in People With and Without HIV.
    Silverberg MJ; Levine TM; Lea AN; Williams AE; Alexeeff SE; Bryant K; Cavassini M; Flamm JA; Hare CB; Ingle SM; Justice AC; Lam JO; Sterling SA; Horberg MA; Satre DD
    Clin Infect Dis; 2024 May; 78(5):1264-1271. PubMed ID: 38227614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes in People with HIV.
    Sarkar S; Brown TT
    Curr Diab Rep; 2021 Mar; 21(5):13. PubMed ID: 33730223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of Cardiometabolic Diseases in People With and Without Human Immunodeficiency Virus in the United Kingdom: A Population-Based Matched Cohort Study.
    Gooden TE; Gardner M; Wang J; Jolly K; Lane DA; Benjamin LA; Mwandumba HC; Kandoole V; Lwanga IB; Taylor S; Manaseki-Holland S; Lip GYH; Nirantharakumar K; Thomas GN
    J Infect Dis; 2022 Apr; 225(8):1348-1356. PubMed ID: 34417792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular Disease Among Persons Living With HIV: New Insights Into Pathogenesis and Clinical Manifestations in a Global Context.
    Ntsekhe M; Baker JV
    Circulation; 2023 Jan; 147(1):83-100. PubMed ID: 36576956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular disease in HIV infection.
    Palella FJ; Phair JP
    Curr Opin HIV AIDS; 2011 Jul; 6(4):266-71. PubMed ID: 21546831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brief Report: Relationship Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease in Persons With HIV.
    Kaplan A; Simon TG; Henson JB; Wang T; Zheng H; Osganian SA; Rosenblatt R; Lake J; Corey KE
    J Acquir Immune Defic Syndr; 2020 Aug; 84(4):400-404. PubMed ID: 32235172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in statin utilization and lipid lowering by race, ethnicity, and HIV status in a real-world cohort of persons with human immunodeficiency virus and uninfected persons.
    Riestenberg RA; Furman A; Cowen A; Pawlowksi A; Schneider D; Lewis AA; Kelly S; Taiwo B; Achenbach C; Palella F; Stone NJ; Lloyd-Jones DM; Feinstein MJ
    Am Heart J; 2019 Mar; 209():79-87. PubMed ID: 30685678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune correlates of cardiovascular co-morbidity in HIV infected participants from South India.
    Kausalya B; Saravanan S; Pallikkuth S; Pahwa R; Saini SR; Iqbal S; Solomon S; Murugavel KG; Poongulali S; Kumarasamy N; Pahwa S
    BMC Immunol; 2022 May; 23(1):24. PubMed ID: 35581554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Evolving Landscape of ASCVD Risk Among Patients With HIV.
    Malvestutto C
    J Fam Pract; 2022 Jul; 71(6 Suppl):S58-S62. PubMed ID: 35960946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyslipidemia in Human Immunodeficiency Virus Disease: JACC Review Topic of the Week.
    Kalra DK; Vorla M; Michos ED; Agarwala A; Virani S; Duell PB; Raal FJ
    J Am Coll Cardiol; 2023 Jul; 82(2):171-181. PubMed ID: 37407116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular Disease, Statins, and HIV.
    Eckard AR; Meissner EG; Singh I; McComsey GA
    J Infect Dis; 2016 Oct; 214 Suppl 2(Suppl 2):S83-92. PubMed ID: 27625435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular Disease Prevention Policy in Human Immunodeficiency Virus: Recommendations From a Modeling Study.
    Smit M; van Zoest RA; Nichols BE; Vaartjes I; Smit C; van der Valk M; van Sighem A; Wit FW; Hallett TB; Reiss P;
    Clin Infect Dis; 2018 Feb; 66(5):743-750. PubMed ID: 29029103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins for primary cardiovascular disease prevention among people with HIV: emergent directions.
    Fitch KV; Fulda ES; Grinspoon SK
    Curr Opin HIV AIDS; 2022 Sep; 17(5):293-300. PubMed ID: 35938463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Canadian HIV and aging cohort study - determinants of increased risk of cardio-vascular diseases in HIV-infected individuals: rationale and study protocol.
    Durand M; Chartrand-Lefebvre C; Baril JG; Trottier S; Trottier B; Harris M; Walmsley S; Conway B; Wong A; Routy JP; Kovacs C; MacPherson PA; Monteith KM; Mansour S; Thanassoulis G; Abrahamowicz M; Zhu Z; Tsoukas C; Ancuta P; Bernard N; Tremblay CL;
    BMC Infect Dis; 2017 Sep; 17(1):611. PubMed ID: 28893184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-Related Myocardial Fibrosis: Inflammatory Hypothesis and Crucial Role of Immune Cells Dysregulation.
    Teer E; Dominick L; Mukonowenzou NC; Essop MF
    Cells; 2022 Sep; 11(18):. PubMed ID: 36139400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.